About Bayer Aktiengesellschaft (BAYN)
Bayer Aktiengesellschaft is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Leverkusen, Germany. BAYN has been publicly traded since 1996, giving it 30+ years of trading history.
Bayer Aktiengesellschaft (BAYN) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Leverkusen, Germany and employs approximately 87,280 people. With a market capitalization of €38 billion, BAYN is a large established company.
BAYN trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap-cap stock with a market capitalization of approximately €38 billion. The company employs approximately 87,280 people worldwide.
Key Statistics
- Current Price
- €38.64
- Market Cap
- €37.96B
- 52-Week High
- €49.78
- 52-Week Low
- €18.38
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
BAYN Investment Performance
BAYN has gained 4.4% year-to-date in 2026. Over the past 5 years, a €1,000 investment in BAYN would have grown to €807, representing a -19.3% total return. Since its IPO in 1996, a €1,000 investment would now be worth €2,517.
€1,000 Invested in Bayer Aktiengesellschaft (BAYN)
How much would €1,000 invested in BAYN be worth today?
What would €1,000 invested in BAYN 1 year ago be worth today?
A €1,000 investment in Bayer Aktiengesellschaft (BAYN) in 2025 would be worth €1,759 as of March 2026, representing a +75.9% total return.
What would €1,000 invested in BAYN 3 years ago be worth today?
A €1,000 investment in Bayer Aktiengesellschaft (BAYN) in 2023 would be worth €692 as of March 2026, representing a -30.9% total return.
What would €1,000 invested in BAYN 5 years ago be worth today?
A €1,000 investment in Bayer Aktiengesellschaft (BAYN) in 2021 would be worth €807 as of March 2026, representing a -19.3% total return.
What would €1,000 invested in BAYN 10 years ago be worth today?
A €1,000 investment in Bayer Aktiengesellschaft (BAYN) in 2016 would be worth €507 as of March 2026, representing a -49.3% total return.
What would €1,000 invested in BAYN at IPO be worth today?
A €1,000 investment in Bayer Aktiengesellschaft (BAYN) at IPO would be worth €2,517 as of March 2026, representing a +151.7% total return.
Monthly Returns Heatmap
Over the past 29+ years (351 months), Bayer Aktiengesellschaft (BAYN) has averaged a monthly return of +0.65% with a median return of +1.08%. The stock had 191 positive months (54%) and 160 negative months (46%). The best month in BAYN's history was April 2003 with a +38.3% return, while the worst was September 2002 at -28.0%. Historically, April tends to be the strongest month (averaging +4.8%), and August the weakest (-3.3%).
BAYN's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2025 with a cumulative return of +69.9%, and the worst was 2024 at -48.4%.
Annual Returns
Over 30 years of trading history, Bayer Aktiengesellschaft (BAYN) has delivered an average annual return of +7.94% with a median return of +5.96%. The compound annual growth rate (CAGR) is +3.12%. The stock posted gains in 21 years (70%) and losses in 9 years (30%).
BAYN's best year was 2025 with a +92.54% gain, while the worst was 2024 at -42.34%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. BAYN achieved double-digit gains (10%+) in 12 years. It suffered double-digit losses in 8 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +4.39% | €37.01 | €38.63 |
| 2025 | +92.54% | €19.22 | €37.01 |
| 2024 | -42.34% | €33.33 | €19.22 |
| 2023 | -27.50% | €45.98 | €33.33 |
| 2022 | +6.20% | €43.29 | €45.98 |
| 2021 | +1.34% | €42.72 | €43.29 |
| 2020 | -30.79% | €61.73 | €42.72 |
| 2019 | +25.96% | €49.01 | €61.73 |
| 2018 | -39.17% | €80.56 | €49.01 |
| 2017 | +7.47% | €74.97 | €80.56 |
| 2016 | -12.22% | €85.40 | €74.97 |
| 2015 | +4.19% | €81.97 | €85.40 |
| 2014 | +13.18% | €72.42 | €81.97 |
| 2013 | +45.21% | €49.87 | €72.42 |
| 2012 | +49.97% | €33.25 | €49.87 |
| 2011 | -8.35% | €36.28 | €33.25 |
| 2010 | +1.78% | €35.65 | €36.28 |
| 2009 | +39.79% | €25.50 | €35.65 |
| 2008 | -31.89% | €37.44 | €25.50 |
| 2007 | +56.87% | €23.87 | €37.44 |
| 2006 | +18.29% | €20.18 | €23.87 |
| 2005 | +44.64% | €13.95 | €20.18 |
| 2004 | +9.82% | €12.70 | €13.95 |
| 2003 | +19.99% | €10.59 | €12.70 |
| 2002 | -41.46% | €18.08 | €10.59 |
| 2001 | -33.99% | €27.40 | €18.08 |
| 2000 | +24.60% | €21.99 | €27.40 |
| 1999 | +28.69% | €17.09 | €21.99 |
| 1998 | +5.32% | €16.22 | €17.09 |
| 1997 | +5.71% | €15.35 | €16.22 |
BAYN Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Bayer Aktiengesellschaft as an investment
Valuation
The forward P/E ratio is 8.1. The price-to-book ratio stands at 1.5. The price-to-sales ratio is 0.8.
Dividends
Bayer Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.28%. This translates to €0.11 per share annually. The payout ratio of 2% indicates sustainable dividend coverage.
Risk & Volatility
BAYN has a beta of 0.93, indicating it is similarly volatile to the overall market. The stock's 52-week range is €18.38 to €49.78, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 19 analyst opinions, BAYN has a consensus "buy" rating. The average price target of €45.73 suggests 18.4% upside from current levels.
Frequently Asked Questions: BAYN
What sector is BAYN in? ▼
BAYN operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has BAYN performed historically? ▼
Over 30 years of trading history, BAYN has posted gains in 21 years (70% of the time). The best year was 2025 with a +92.5% return. Past performance does not guarantee future results.
How can I invest in BAYN? ▼
You can invest in BAYN through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BAYN.
Does BAYN pay dividends? ▼
Bayer Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.28%. This translates to €0.11 per share annually. The payout ratio of 2% indicates sustainable dividend coverage.
What does Bayer Aktiengesellschaft do? ▼
Bayer Aktiengesellschaft is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Leverkusen, Germany.
What sector is BAYN in? ▼
BAYN operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did BAYN go public? ▼
Bayer Aktiengesellschaft went public in 1996, making it a 30-year-old public company as of 2026.
How much would €1,000 invested in BAYN 5 years ago be worth today? ▼
A €1,000 investment in BAYN five years ago would be worth approximately €807 today, representing a -19.3% return.
How much would €1,000 invested in BAYN 10 years ago be worth today? ▼
A €1,000 investment in BAYN ten years ago would be worth approximately €507 today, representing a -49.3% total return over the decade.
What is BAYN's 3-year return? ▼
Over the past 3 years, BAYN has returned -30.9%. A €1,000 investment would have grown to €692.
How much would €1,000 invested in BAYN at IPO be worth today? ▼
If you invested €1,000 in BAYN at its IPO in 1996, it would be worth approximately €2,517 today, a 151.7% return over 30 years.
Does BAYN pay dividends? ▼
Yes, Bayer Aktiengesellschaft pays a dividend with a current yield of 0.28%, which is €0.11 per share annually.
What is BAYN's market cap? ▼
Bayer Aktiengesellschaft has a market capitalization of €38 billion, classifying it as a large-cap company.
Is BAYN a buy, hold, or sell? ▼
Based on 19 opinions, BAYN has a consensus "buy" rating. The average price target is €45.73.
Last updated: 3/15/2026